September 03, 2014
Gilead Sciences to Present at Two Upcoming Investor Conferences in September
- Robert W. Baird & Co. 2014 Health Care Conference -
- 2014 Morgan Stanley Global Healthcare Conference -
- Webcasts Available Through Gilead Corporate Website -
FOSTER CITY, Calif.--(BUSINESS WIRE)--Sep. 3, 2014--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate
presentation will be webcast from two upcoming investor conferences: the
Robert W. Baird & Co. 2014 Health Care Conference and the 2014 Morgan
Stanley Global Healthcare Conference, both taking place in New York.
John F. Milligan, PhD, Gilead’s President and Chief Operating Officer,
will provide an overview of the company at the Baird conference on
Thursday, September 4 at 10:15 a.m. Eastern Time (ET) and the Morgan
Stanley conference on Tuesday, September 9 at 11:10 a.m. ET.
To access the live webcast or a replay via the internet log on to www.gilead.com.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be necessary to listen to the webcast. The replay will
be available for 14 days following the presentation.
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Headquartered in Foster City,
California, Gilead has operations in North and South America, Europe and
For more information on Gilead Sciences, please visit www.gilead.com
or call the Gilead Public Affairs Department at 1-800-GILEAD-5
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936